Ciraparantag as a potential universal anticoagulant reversal agent
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 7, 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Anticoagulants (MeSH)
- Anticoagulation Reversal (MeSH)
- Arginine (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Piperazines (MeSH)
published in
- European Heart Journal Journal